Clinical Vignette Series - 39th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow®
Clinical Vignette Series - 39th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® is organized by Physicians' Education Resource, LLC (PER).
Activity Overview:
In this Clinical Vignette Series: 39th Annual Chemotherapy Foundation Symposium (CFS®): Innovative Cancer Therapy for Tomorrow®, oncology thought leaders address clinical challenges faced by community oncologists and offer their insights on the clinical application of new data and advances. This interactive, online activity features a series of case-based vignettes, self-reflection questions, and brief video clips in which the program faculty share their approaches to oncology care. This activity touches on established and emerging standards of care in diffuse large B-cell lymphoma and multiple myeloma, as well as breast, lung, kidney, bladder, gastric, colorectal, and ovarian cancers. It is based on content presented at the 2021 CFS® meeting, an annual gathering with a long-standing history of providing education, guidance, perspectives, and solutions to practicing oncologists. Delivering state-of-the-art cancer care requires the incorporation of new clinical advances and data into practice.
Learning Objectives:
Upon successful completion of this activity, you should be better prepared to:
• Determine the most appropriate testing strategies to identify molecular markers and treatment targets while stratifying risk to inform clinical decision-making in cancer management
• Describe key practice-changing clinical trial results that inform appropriate diagnostic and treatment approaches for patients with hematologic malignancies and solid tumors
• Identify evidence-based immunotherapeutic, chemotherapeutic, and targeted treatment strategies to optimize clinical outcomes
• Delineate implementation strategies for multidisciplinary teams to anticipate and proactively manage treatment-related toxicities
• Review practice-changing evidence presented at major conferences, and apply these findings to optimize the care of patients with cancer
Additional details will be posted as soon as information is available.